UnitedHealth Group beat Wall Street by 55 cents a share on Tuesday, and one line in its own earnings release is worth about 53 of them.
- Adjusted earnings were $4.69 a share. Analysts surveyed by LSEG expected $4.14. A year ago the figure was $2.92.
- The full-year floor moved to “at least $20.50” from a range of $19.50 to $20.00. It is the third increase since January.
- The medical care ratio, the share of premiums paid out in claims, fell to 88.4% from 89.9%.
- The release adds that the ratio “was impacted by $610 million of net favorable prior period reserve development related to 2026 dates of service.”
- Shares rose about 3% before the open.
The fourth item explains the first. Favorable development means claims from earlier months came in below what the company had set aside, and the difference lands in this quarter’s profit. Taxed at the quarter’s 22% rate, $610 million is about $475 million. Spread across 902 million diluted shares, that is 53 cents.
It also flatters the ratio everyone is quoting. Put the $610 million back into medical costs and 88.4% becomes 89.1%. That is still better than last year. It is about half as much better.
What the Third Quarter Took From the First Half
| Measure | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | $112.7 billion | $113.2 billion |
| Medical care ratio | 88.4% | 89.9% |
| Favorable reserve development | $610 million | $80 million |
| Medicare Advantage members | 7.6 million | 8.4 million |
| Adjusted earnings per share | $4.69 | $2.92 |
None of this is a trick. The cash is real, and days claims payable stood at 47.0, up from 44.1 at the end of 2025, so the cushion has not been raided. What the line describes is first-half profit arriving late. UnitedHealth booked $860 million of the same thing in the second quarter. For all of 2025 the total was $140 million. A company that reserved cautiously in the spring is collecting on its own caution now, and a reserve that releases this quickly is not a run rate. Chief Financial Officer Wayne DeVeydt came close to saying so himself, telling CNBC that costs “continue to be elevated versus historical norms” and that he did not want the improved ratio “to be misleading.”
Then read what the new floor implies. Nine months of adjusted earnings add up to $18.30 a share. A floor of $20.50 leaves $2.20 for the fourth quarter, against $2.11 a year earlier. Through September the company ran 29% ahead of 2025. Its own guidance has it finishing 4% ahead. “At least” leaves room above the floor, and the fourth quarter is always the weakest for insurers. Still, a management team that believed 88.4% was the new normal would not write that number.
Our read: the turnaround is real, and it is narrower than a 55-cent beat suggests. UnitedHealth is reaching its margin by getting smaller. Revenue fell. It covers 830,000 fewer Medicare Advantage members than a year ago and 865,000 fewer people in fully insured employer and individual plans, a contraction it told investors in January to expect. The stock is being rewarded for insuring fewer of the people who cost the most to insure, and investors should say that plainly instead of calling it execution. Those seniors still need care. They moved onto a rival’s book or back into traditional Medicare, and the cost went with them. Value the company on 89.1% and a $2.20 quarter, and ask where the 830,000 went.